The eClinical Medicine of Lancet Published Phase 2 Results of Ivonescimab for the Treatment of NSCLC ...Middle East

HONG KONG, Aug. 7, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that eClinical Medicine(IF:15.1), a...

Hence then, the article about the eclinical medicine of lancet published phase 2 results of ivonescimab for the treatment of nsclc was published today ( Monday 07/08/2023 - 07:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The eClinical Medicine of Lancet Published Phase 2 Results of Ivonescimab for the Treatment of NSCLC )

Also on site :

• 17 Athletes to Watch at the 2026 Winter Olympics—Including Lindsey Vonn’s Historic Return
• The Best 5 One Chicago Couples Of All Time
• ‘The Traitors’ Issues Statement Addressing Bullying and Harassment of Cast Members